Clinical Trial Update: Axicabtagene Ciloleucel:Neurocognitive and Patient-Reported Outcomes

View source ↗

Summary

Clinical trial update reporting on neurocognitive effects and patient-reported outcomes for axicabtagene ciloleucel in diffuse large B-cell lymphoma and transfo…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diffuse Large B-cell Lymphoma
• Transformed Lymphoma

Drugs mentioned

• Yescarta (axicabtagene ciloleucel)

Snippet

Sponsor: H. Lee Moffitt Cancer Center and Research Institute | Conditions: Diffuse Large B Cell Lymphoma, Transformed Lymphoma | Status: COMPLETED